The Centers for Disease Control (CDC) yesterday published its COVID-19 vaccine procurement contract with Taiwan-based Medigen Vaccine Biologics Corp (高端疫苗) after the company’s board of directors agreed to an early disclosure of the agreement.
The Chinese Nationalist Party (KMT) had repeatedly asked the CDC to publish the contract, saying the government might be concealing secrets from the public.
Premier Chen Chien-jen (陳建仁) last week said the government could not unilaterally disclose the contract due to a confidentiality agreement, but that it was negotiating with Medigen in hopes that it would agree to an early disclosure.
Photo: CNA
At an impromptu news conference yesterday afternoon, CDC Director-General Chuang Jen-hsiang (莊人祥) said Medigen informed the agency at 3:30pm yesterday that its board of directors had agreed to let it publish the contract.
Chuang said the CDC and Medigen had signed a procurement contract and a confidentiality agreement, ensuring that both sides do not disclose the details of the contract, which is in line with international commercial practices, and that many governments have also signed confidentiality agreements when they signed procurement contracts with vaccine producers.
The procurement contract was signed on May 28, 2021, according to the Public Construction Commission’s procurement contract template, but it lacked a commercial confidentiality agreement, so both sides had an oral contract to adhere to non-disclosure obligations, he said.
Medigen on June 8, 2021, asked to sign a supplementary confidentiality agreement to prevent leaks of ingredients, which was signed on July 19, 2021, he added.
According to the confidentiality agreement with Medigen, the confidentiality period was set at five years after the date of signing, but to bolster the public’s confidence, both sides agreed to disclose the information earlier, he said.
There is no agreement to keep the contract “sealed for 30 years” as some politicians have claimed, he said.
Confidentiality agreements for vaccine procurement are not new, as the CDC also signed a seven-year confidentiality agreement with Novartis when it purchased the influenza A (H1N1) monovalent vaccine in 2009, and agreements with different confidentiality periods were signed with AstraZeneca, Pfizer-BioNTech, and Moderna for their COVID-19 vaccines, he said.
Regarding vaccine prices, he said that when the Central Epidemic Command Center (CECC) announced in November 2020 that it planned to spend NT$11.5 billion (US$366.34 million) to purchase 15 million doses — or about NT$700 per dose — it was an estimated price that did not include cold chain logistics and other costs.
During the bargaining process from February to May 2021, Medigen offered a quote of NT$950 per dose, and the CDC negotiated the price to NT$881 apiece for single-dose vials and NT$810 for multi-dose vials, Chuang said.
The company must also the distribute the vaccine to no fewer than 200 locations, and be responsible for the vaccines from inspection to shipping, and the cost of disposal and other operating fees, he said.
The company had previously disclosed the prices of the vaccine and now that the full contract has been published with the consent of both sides, there is no breach of contract and it would not affect the CDC’s credit in purchasing vaccines in future, he said.
The 58-page vaccine procurement contract has been published on the CDC’s official Web site.
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
Taiwan’s passport ranked 34th in the world, with access to 141 visa-free destinations, according to the latest update to the Henley Passport Index released today. The index put together by Henley & Partners ranks 199 passports globally based on the number of destinations holders can access without a visa out of 227, and is updated monthly. The 141 visa-free destinations for Taiwanese passport holders are a slight decrease from last year, when holders had access to 145 destinations. Botswana and Columbia are among the countries that have recently ended visa-free status for Taiwanese after “bowing to pressure from the Chinese government,” the Ministry
HEALTHCARE: Following a 2022 Constitutional Court ruling, Taiwanese traveling overseas for six months would no longer be able to suspend their insurance Measures allowing people to suspend National Health Insurance (NHI) services if they plan to leave the country for six months would be abolished starting Dec. 23, NHIA Director-General Shih Chung-liang (石崇良) said yesterday. The decision followed the Constitutional Court’s ruling in 2022 that the regulation was unconstitutional and that it would invalidate the regulation automatically unless the NHIA amended it to conform with the Constitution. The agency would amend the regulations to remove the articles and sections that allow the suspension of NHI services, and also introduce provisional clauses for those who suspended their NHI services before Dec. 23, Shih said. According to
‘GRAY ZONE’ TACTICS: China continues to build up its military capacity while regularly deploying jets and warships around Taiwan, with the latest balloon spotted on Sunday The US is drawing up contingency plans for military deployments in Japan and the Philippines in case of a Taiwan emergency, Japan’s Kyodo news agency reported. They would be incorporated in a first joint operation plan to be formulated in December, Kyodo reported late on Sunday, citing sources familiar with Japan-US relations. A US Marine Corps regiment that possesses High Mobility Artillery Rocket Systems — a light multiple rocket launcher — would be deployed along the Nansei Island chain stretching from Kyushu to Yonaguni near Taiwan, Kyodo said. According to US military guidelines for dispatching marines in small formations to several locations,